Press Releases

Periodontal Therapeutics Market Sales & Revenues have rapidly increased Worldwide due to gigantic Demands from all corners of the Globe To 2022-2030

Share This Article

The global periodontal therapeutics market for the historical period 2017–2018 and forecast period 2019–2027, rise in reported cases of periodontitis, Increase in prevalence of diabetes, rise in global geriatric population and surge in awareness about oral health are projected to drive the global periodontal therapeutics market

Get the sample copy of report@

According to the report, the global periodontal therapeutics market was valued at US$ 536.8 Mn in 2018 and is anticipated to expand at a CAGR of 8.8% from 2019 to 2030

Rise in Global Burden of Periodontal Diseases: A Key Driver

Periodontal diseases comprising gingivitis and periodontitis are prevalent both in developing and developed countries and affect around 20% to 50% of the global population

According to the Global Burden of Disease Study (GBD, 1990–2010), severe periodontitis is the 6th most prevalent disease worldwide, and has an overall prevalence of 11.2% and an estimated 743 million people worldwide are affected by it. The global burden of periodontal diseases has increased by as much as 57.3% from 1990 to 2010.

Periodontitis is one of the major causes of tooth loss in adult population across the world. These individuals are at risk of edentulism, masticatory dysfunction, and multiple tooth loss which in turn affects nutrition, self-esteem, and quality of life as well as imposes high health care and significant socio-economic costs.

The global cost of lost productivity due to severe periodontitis is estimated to be around US$ 54 Bn per year, while the total economic impact of periodontal diseases accounts for a major component of the US$ 442 Bn direct and indirect cost caused due to oral diseases.

Surge in Awareness About Oral Health to Augment Global Market

Oral health programs work for formulation of national and community policies on effective control of diet and nutrition risk factors for oral diseases such as periodontal disease, dental disease, etc.

Periodontal diseases have a significant socio-economic impact on populations and governments across the world; however, treatment to these diseases still remains unavailable in developing countries due to low priority accorded to these diseases

The Global Periodontal Health Project (GPHP) was launched in October 2015 in order to reduce the overall global burden of periodontal diseases. The project aims to decrease the burden associated with these diseases by raising awareness of its impact and engaging oral health and other health professionals, policymakers, educators, and the general public in promoting periodontal health.

The Global Periodontal Health Project aims to make periodontal health a priority issue at the national level by engaging with Ministers of Health, Chief Dental Officers and the local populations, and also increase the disease awareness levels by actively disseminating dental educational promotional tools.

Uninsured Dental Care in Several Developed and Developing Countries to Hamper Global Periodontal Therapeutics Market

Advanced dental and periodontal procedures turn out to be too expensive for an average citizen in both developed and developing countries

Oral health care coverage is seen to be low in low- and middle-income countries. Dental care is not insured in several developed countries such as Canada and the U.S. In the U.S., only the most rudimentary dental care is covered by health insurance plan. According to the National Association of Dental Plans, over 114 million people in the U.S. were known to be without dental coverage in 2014.

View full report@

North America to Account for Major Share of Global Periodontal Therapeutics Market

North America is projected to account for leading share of the global periodontal therapeutics market due to rise in product approvals, well-established health care infrastructure, increase in technological advancements, rise in number of well-equipped laboratories, surge in research & developmental activities in periodontal therapeutics, and presence of key players

The periodontal therapeutics market in Asia Pacific is projected to grow at a rapid pace during the forecast period due to increase in geriatric population, rise in research & developmental activities, surge in initiatives by governments in the health care sector, and rise in interest of key players in expanding presence in the region

Global Periodontal Therapeutics Market: Competitive Landscape

This report profiles major players in the global periodontal therapeutics market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments

Key players operating in the global periodontal therapeutics market include

  • Den-Mat Holdings, LLC
  • Valeant Pharmaceuticals International, Inc.
  • Dexcel Pharma
  • 3M Company
  • Oral Science
  • Kaken Pharmaceutical Co., Ltd.

Key Questions Answered in Global Periodontal Therapeutics Market Report

  • What is the scope of growth of product companies in the global periodontal therapeutics market?
  • What will be the Y-o-Y growth of the global periodontal therapeutics market between 2019 and 2027?
  • What is the influence of pipeline Systemic Antibiotics on the global periodontal therapeutics market?
  • Will North America continue to be the most profitable market for providers of periodontal therapeutics treatment products?
  • Which factors will hamper the growth of the global periodontal therapeutics market during the forecast period?
  • Which are the leading companies in the global periodontal therapeutics market?

Purchase Complete Report Now@

Global Periodontal Therapeutics Market – Segmentation


  • Systemic Antibiotics
  • Doxycycline
  • Minocycline
  • Metronidazole
  • Others
  • Local Antibiotics
  • Arestin
  • Periochip
  • Atridox
  • Others

Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug Stores
  • E-Commerce


  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa


1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Periodontal Therapeutics Market

4. Market Overview

4.1. Introduction

4.1.1. Product Definition

4.2. Overview

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunities

4.4. Global Periodontal Therapeutics Market Analysis and Forecast, 2017–2027

4.4.1. Market Revenue Projections (US$ Mn)

4.5. Porter’s Five Force Analysis

5. Market Outlook

5.1. Pricing Analysis

5.2. Pipeline Analysis

5.3. Re-imbursement Scenario

6. Global Periodontal Therapeutics Market Analysis and Forecast, by Product

6.1. Introduction & Definition

6.2. Key Findings / Developments

6.3. Market Value Forecast, by Product, 2017–2027

6.3.1. Systemic Antibiotics Doxycycline Minocycline Metronidazole Others

6.3.2. Local Antibiotics Arestin Periochip Atridox Others

6.4. Market Attractiveness, by Product

7. Global Periodontal Therapeutics Market Analysis and Forecast, by Distribution Channel

7.1. Introduction & Definition

7.2. Key Findings / Developments

7.3. Market Value Forecast, by Distribution Channel, 2017–2027

7.3.1. Hospitals Pharmacies

7.3.2.  Retail Pharmacies

7.3.3. Drug Stores

7.3.4. E-Commerce

7.4. Market Attractiveness Analysis, by Distribution Channel

8. Global Periodontal Therapeutics Market Analysis and Forecast, by Region

8.1. Key Findings

8.2. Market Value Forecast, by Region

8.2.1. North America

8.2.2. Europe

8.2.3. Asia Pacific

8.2.4. Latin America

8.2.5. Middle East & Africa

8.3. Market Attractiveness Analysis, by Region

9. North America Periodontal Therapeutics Market Analysis and Forecast

9.1. Introduction

9.1.1. Key Findings

9.2. Market Value Forecast By Product, 2017–2027

9.2.1. Systemic Antibiotics Doxycycline Minocycline Metronidazole Metronidazole Others

9.2.2. Local Antibiotics Arestin Periochip Atridox Others

9.3. Market Value Forecast, by Distribution Channel, 2017–2027

9.3.1. Hospitals Pharmacies

9.3.2.  Retail Pharmacies

9.3.3. Drug Stores

9.3.4. E-Commerce

9.4. Market Value Forecast, by Country, 2017–2027

9.4.1. U.S.

9.4.2. Canada

9.5. Market Attractiveness Analysis

9.5.1. By Product

9.5.2. By Distribution Channel

9.5.3. By Country

10. Europe Periodontal Therapeutics Market Analysis and Forecast


Purchase Complete Report Now@

You can place an order or ask any questions, please feel free to contact | +1 9197 992 333

About Us

QYResearch Medical, focuses on custom research, management consulting, IPO consulting, industry chain research, and data base & seminar services. The company owns large basic databases (such as National Bureau of Statistics Database, Customs Import and Export Database, Industry Association Database, etc.), expert resources (including industry experts who own more than 10 years experiences on marketing or R&D in industries of healthcare services, medical technology & devices, etc.), professional survey team (the team members obtained more than 3 years market survey experience and more than 2 years deep expert interview experience), and excellent data analysis team (SPSS statistics and PPT graphics process team).

QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover China, US, EU, Asia, Middle East and Africa, South America, Australia, and other regions in the world.

For Latest Update Follow Us:

Related Articles

Back to top button